Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...
The rationale for subphenotyping acute respiratory distress syndrome (ARDS) arises from its marked biological and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback